Gestational surrogacy requires comprehensive medical planning that begins well before the embryo transfer and continues throughout the pregnancy, the birth, and the surrogate’s postpartum recovery; therefore, for intended parents, understanding these clinical stages helps clarify what decisions must be made, which professionals will guide the process, and why the medical roadmap is tailored specifically to each family.
Although the goal is to achieve a healthy pregnancy and support its development, not all families begin under the same clinical conditions because some already have created and cryopreserved embryos; conversely, others need to initiate a full assisted reproduction cycle. Furthermore, maternal age, the necessity of utilizing donor eggs or sperm, and the specific physiological characteristics of the gestational carrier heavily influence the overall clinical planning.
At ALUMA, we believe it is essential for intended parents to understand this medical journey without having to become specialists themselves; consequently, we outline the primary clinical phases and explain the function of each milestone, from the initial screening to the essential postpartum care.
In gestational surrogacy, which is the model we operate, the pregnancy is achieved by transferring an embryo created via assisted reproductive technologies into the uterus of the gestational carrier; therefore, she shares no genetic connection with the child because she does not provide the egg used to create the embryo.
The overall medical process generally encompasses the following stages:
- Comprehensive medical evaluation of the intended parents and donors, when applicable.
- Egg retrieval and sperm collection procedures.
- In vitro fertilization and laboratory embryo cultivation.
- Embryo grading and additional preimplantation testing when clinically indicated.
- Thorough medical screening of the gestational carrier.
- Endometrial preparation of the uterus for the transfer.
- The embryo transfer procedure.
- Clinical testing and ultrasounds to confirm pregnancy.
- Dedicated prenatal and obstetric monitoring.
- Labor, delivery, and structured postpartum care.
Not every family needs to navigate these stages in the exact same manner; for instance, if you already have cryopreserved embryos available, it is not necessary to undergo a new ovarian stimulation or egg retrieval cycle. On the other hand, certain cases require specialized screenings or a distinct timeline based on previous reproductive histories.
For this reason, the medical team must establish a personalized strategy centered on the clinical history and the specific circumstances of all participants.

- A detailed review of the clinical history and past reproductive outcomes.
- Advanced fertility assessments and hormone panels when necessary.
- Diagnostic lab work related to overall reproductive health.
- Semen analysis and evaluations of ovarian function, depending on the case.
- Comprehensive screening for infectious diseases and infectious markers.
- Preimplantation genetic screening when medical indications are present.
Genetic studies help identify specific hereditary disorders or assess potential risks associated with family medical histories; however, they are not applied uniformly to all patients or across every assisted reproduction process.
When specialists recommend these advanced laboratory tests, it is important that the findings are explained clearly and thoroughly; consequently, intended parents can fully grasp their clinical scope and understand the potential decisions that may arise from the results.
The physical health of the woman who will carry the pregnancy is a foundational cornerstone of the entire planning process; therefore, prior to the transfer, the medical team must carefully evaluate whether any underlying conditions could increase obstetric risks and ensure that her overall health and uterine lining are fully compatible with the planned pregnancy.
This clinical evaluation generally encompasses:
The specific diagnostic studies depend on the carrier’s medical history and the established clinical protocols; for example, understanding how her previous pregnancies progressed provides invaluable data to evaluate potential obstetric risks and structure her prenatal care.
This evaluation should never be viewed merely as a bureaucratic program requirement because its true purpose is to identify specific medical needs, assess her physical readiness to carry a healthy pregnancy, and ensure the gestational carrier has complete, transparent information to make fully informed decisions.
Any gestational surrogacy journey involves complex decisions that carry emotional and familial implications alongside the medical milestones; for this reason, a professional psychological evaluation forms an integral part of a comprehensive preparation strategy for everyone involved; this professional guidance helps explore the clear understanding of the process, personal expectations, the strength of the local support network, and potential situations of emotional pressure; furthermore, it identifies specific counseling needs before, during, and after the pregnancy.
For intended parents, professional psychological support is highly effective in navigating the normal uncertainty that accompanies assisted reproduction treatments and the different stages of the journey. Ultimately, this evaluation should not be minimized as a tool to approve or reject a participant, but rather as a resource that ensures decisions are made with absolute freedom, clarity, and knowledge.
In vitro fertilization (IVF) is the primary assisted reproductive technology utilized in a surrogacy journey to create embryos within a controlled laboratory environment; thus, it allows the clinical team to combine eggs and sperm from the intended parents or from selected donors.
Generally speaking, a standard IVF cycle encompasses the following phases:
- Initial medical screening and baseline testing.
- Controlled ovarian stimulation, applicable when using the intended mother’s eggs.
- Continuous monitoring of ovarian response via clinical ultrasounds and blood work.
- The egg retrieval procedure.
- Sperm collection and specialized laboratory preparation.
- Fertilization within the embryology laboratory.
- Monitored development and cultivation of the embryos.
- Embryo grading and morphology assessment.
- Preimplantation genetic testing, when clinically indicated.
- Cryopreservation and secure storage of the embryos, if applicable.
- Clinical preparation for the upcoming embryo transfer.
The exact sequence and overall duration of the treatment depend entirely on the medical circumstances and the specific plan designed by the clinic; furthermore, if the family already possesses cryopreserved embryos, several of these initial phases are bypassed completely.

Following fertilization, the embryos remain in the laboratory for a specific period during which the embryology team closely monitors their cellular division; in this way, they can observe how they evolve and determine which embryos are ideal candidates for a transfer.
In specific scenarios, the medical team may also recommend preimplantation genetic testing of the embryos. This indication depends on several variables, including previous reproductive outcomes, identified genetic risks, and the specific clinical circumstances of the couple.
En determinados casos también pueden recomendarse estudios genéticos de los embriones. La indicación depende, entre otros factores, de los antecedentes reproductivos, los riesgos identificados y las circunstancias clínicas.
It remains essential to understand that while embryo grading provides crucial diagnostic data for decision-making, it does not guarantee a successful implantation or an entire pregnancy free from subsequent clinical complications.
Yes. Embryos can be safely preserved through an advanced fast-freezing procedure known as vitrification or cryopreservation; consequently, this technique allows them to be stored securely for future use, making it possible to schedule the transfer during a cycle completely separate from the initial egg retrieval.
The choice to freeze embryos and the exact timing of their clinical use must be defined in coordination with the medical team, ensuring the timeline aligns perfectly with the characteristics of your treatment plan.
Before transferring an embryo, the medical team evaluates and prepares the endometrium, which is the tissue that lines the interior of the uterus; therefore, the clinical preparation is synchronized precisely with the treatment type and the physiological characteristics of the gestational carrier.
This preparation phase involves targeted medications and regular clinical checks, although the medical protocol varies because individual histories, past responses to hormones, and specific cycle patterns alter the requirements; for this reason, the preparation must be closely supervised by the fertility specialist, who ultimately determines when the optimal uterine conditions are met to proceed.
The embryo transfer is a brief, specialized procedure through which the selected embryo is gently placed into the uterus of the gestational carrier; while it is performed within the sterile environment of the fertility clinic and represents a momentous milestone in the journey, this step alone does not confirm that a pregnancy has occurred.
When performed with a frozen embryo, the core procedural steps remain identical to those of a fresh cycle, with the primary difference being that the cryopreserved embryo must be thawed right before the procedure and the medical team must program the carrier’s endometrial preparation according to her cycle; consequently, the choice between these two clinical options will always depend on the specific medical variables and the overall strategy established by the fertility center.
The total number of embryos to be transferred must also be decided based on the medical circumstances of the gestational carrier and the overall quality of the available embryos; indeed, the official clinical guidelines from the American Society for Reproductive Medicine (ASRM) strongly favor the transfer of a single embryo to minimize the obstetric risks associated with a multiple pregnancy.
And the final decision rests with the medical team, who is responsible for explaining all options clearly to determine the safest and most effective treatment path for both the gestational carrier and the baby.
Following the transfer, a brief waiting period begins during which the fertility clinic schedules when the blood tests should be performed and determines what subsequent medical controls are necessary; therefore, these diagnostic assessments provide the definitive clinical confirmation of whether implantation was successful.
If the laboratory results confirm a pregnancy, the subsequent ultrasounds monitor the early embryonic development and determine when the care should transition smoothly to standard obstetric monitoring; conversely, if the result is negative, the specialist will thoroughly review the cycle variables and outline the alternative clinical options available.
The most recommended approach during this delicate phase is to take things one step at a time and avoid over-interpreting symptoms, as the final pregnancy test must be evaluated strictly within its proper clinical context by your medical team.

An embryo transfer may occasionally result in a negative test, which does not automatically imply that an identifiable medical error occurred or that the entire journey has failed; this is because implantation depends on complex biological variables and, in many instances, it is not possible to isolate a single definitive cause.
Among the primary areas that the specialist will review are the structural grading of the embryo, the receptive thickness of the endometrium, past reproductive backgrounds, and the precise clinical conditions present during the procedure.
After a thorough case review, the medical team may recommend a subsequent transfer, adjustments to the hormonal preparation protocol, or advanced diagnostic studies; ultimately, the next step depends entirely on the clinical data and the number of embryos that remain securely cryopreserved, as there is no single number of attempts that fits every family and the procedure should never be repeated mechanically.
Once the pregnancy is clinically confirmed, a structured phase of obstetric care begins with the primary focus of safeguarding the health of the gestational carrier and monitoring the steady development of the baby; consequently, the frequency of prenatal visits and specialized scans depends on how the pregnancy evolves and her specific medical background.
Throughout this journey, the care network expands to include professional obstetricians and, when specific clinical circumstances require it, specialists in maternal-fetal medicine or high-risk perinatology to address any unique medical needs.
For intended parents, understanding the general purpose of this monitoring helps distinguish routine prenatal evaluations from targeted diagnostic checks, since prenatal care plans adapt dynamically to the pregnancy’s evolution and not every gestational carrier requires the exact same schedule of visits.
Not all pregnancies achieved through in vitro fertilization (IVF) are categorized as high-risk; however, any pregnancy can develop unexpected complications and certain journeys naturally require closer medical supervision; among the factors that may necessitate enhanced clinical surveillance are past obstetric complications, underlying chronic conditions, gestational hypertension, gestational diabetes, a multiple pregnancy, or acute complications that arise during the months of gestation.
When the medical team identifies specific risk factors, they will recommend additional targeted scans or the active participation of perinatologists because the overarching goal is to tailor the prenatal care to the carrier’s needs and intervene promptly if a complication appears.
At all times, the gestational carrier retains absolute autonomy over her own body and her medical care; therefore, receiving regular medical updates on the pregnancy’s progress as previously agreed does not authorize the intended parents to make clinical decisions in her place, as her explicit consent is the only legally and ethically valid authorization for any medical procedure.
If an obstetric complication arises, the medical team must explain directly to the gestational carrier what is occurring, what clinical alternatives are available, and what treatment is recommended; in this way, all emergency or routine medical decisions remain firmly rooted in transparent clinical data, informed consent, and the immediate health needs of both the carrier and the baby.

Assisted reproduction treatments, including standard IVF, can occasionally result in a multiple pregnancy; however, this specific risk depends heavily on the total number of embryos placed during the procedure because transferring two or more embryos directly increases the probability of multiple implantations. Even when transferring a single embryo, a very low statistical probability remains that it may split, leading to identical twins.
A multiple pregnancy significantly increases the clinical risks of premature labor, low birth weight, and serious obstetric complications for both the gestational carrier and the babies; for this reason, cFor this reason, medical guidelines favor single embryo transfer in surrogacy cycles, a strategy that significantly reduces this risk, though it does not eliminate it entirely
This decision must be made in close consultation with the fertility specialist, who will outline the statistical risks and options based on the specific parameters of your treatment.
The planning of the birth is an ongoing part of the prenatal care during the final months; therefore, the hospital facility and the clinical resources must be selected by carefully considering the overall health of the gestational carrier, the stability of the pregnancy, and the potential needs of the newborn, including the immediate availability of a Neonatal Intensive Care Unit (NICU) if required.
The specific route of delivery, whether vaginal or via a cesarean section, depends strictly on obstetric variables and the final choice rests with the medical team; this decision will be based on factors such as fetal positioning, her past delivery history, the current progression of labor, and any acute complications that may manifest at the time of birth.
Comprehensive medical care does not conclude with the delivery of the baby because the gestational carrier requires structured monitoring during her postpartum recovery while the newborn must receive standard neonatal evaluations and pediatric care; therefore, postpartum care is tailored to her specific recovery needs, focusing on physical healing, monitoring for potential late-onset complications, and providing emotional support.
For intended parents, understanding this final clinical phase is a vital component of a responsible journey, ensuring that the medical attention provided to the gestational carrier continues seamlessly according to the precise indications of the clinical team.
Gestational surrogacy brings together distinct medical phases that are deeply interconnected, from the initial screening and embryo creation to the pregnancy, the delivery, and the essential postpartum recovery; although this structured overview helps clarify how the clinical journey is organized, the actual plan must be established based on the unique circumstances of each family and the expert guidance of fertility specialists.
For this reason, it is essential that intended parents receive transparent information regarding each clinical milestone, understand which decisions depend strictly on medical expertise, and remain aware that physiological timelines and results vary naturally. Ultimately, having a clear grasp of the medical framework empowers you to participate in your journey in a highly informed manner, keeping in mind that every assisted reproduction treatment requires an individualized clinical approach.
Disclaimer: All information available on this website is provided for informational purposes only.
The clinical assessment requires a comprehensive review of certified medical records from every previous delivery; consequently, the fertility specialists evaluate the exact tracking of gestational weeks, birth weights, placental conditions, and any past occurrences of preeclampsia or gestational diabetes to minimize obstetric risks.
Yes. International medical transport is a standard clinical procedure regulated by COFEPRIS in Mexico and the FDA when crossing borders; therefore, specialized cryogenic couriers maintain the liquid nitrogen chain of custody to transfer your vitrified embryos directly between laboratories safely.
Before any laboratory fertilization or embryo transfer can occur, both genetic contributors must undergo standard blood panels for HIV, Hepatitis B and C, syphilis, and Zika virus; indeed, these diagnostic screenings align with international biosecurity mandates to protect everyone involved.
If a structural or developmental variance is identified, the primary obstetrician immediately schedules a detailed evaluation with a certified maternal-fetal medicine specialist; consequently, advanced diagnostic scans are performed to establish an accurate clinical plan based on objective data.
Begin your family journey with our dedicated clinical care
We coordinate every screening and transfer detail for your gestational carrier; therefore, reach out today to design your personalized, secure path home.

Copyright © 2026